Protein kinase C in cancer Signaling and therapy [electronic resource] / edited by Marcelo G. Kazanietz.
- New York, N.Y. : Springer Science+Business Media, LLC, 2010.
- Current cancer research
Current cancer research.
xiv, 494 p. ill.
- Medical subjects:
- Neoplasms -- drug therapy.
Protein Kinase C -- therapeutic use.
Intercellular Signaling Peptides and Proteins.
- System Details:
- Mode of access: Internet.
- Protein kinase C in cancer signaling and therapy: introduction and historical perspective
Regulation of conventional and novel protein kinase C isozymes by phosphorylation and lipids
Phorbol esters and diacylglycerol: the PKC activators
Diacylglycerol signaling: the C1 domain, generation of DAG and termination of signals
Regulation of PKC by protein-protein interaction in cancer
Introduction: PKC isozymes in the control of cell function
Regulation and function of protein kinase C signaling
PKC and control of the cell cycle
PKC and the control of apoptosis
Atypical PKC's, NF-kB and inflammation
Introduction: PKC and cancer
Protein kinase C, p53, and DNA damage
PKCs as mediators of the hedgehog and Wnt signaling pathways
PKC-PKD interplay in cancer
Transgenic mouse models to investigate functional specificity of protein kinase C isoforms in the developoment of squamous cell carcinoma, a nonmelanoma human skin cancer
PKC isozymes and skin cancer
PKC and breast cancer
PKC and prostate cancer
Protein kinase C and lung cancer
Introduction [PKC isozymes as targets for cancer therapy]
PKC and resistance to chemotherapeutic agents
PKCd as a target for chemotherapeutic drugs
Atypical PKCs as targets for cancer therapy.
- Kazanietz, Marcelo G.
SpringerLink (Online service)
- Contained In:
- Springer eBooks
|Location||Notes||Your Loan Policy|
|Description||Status||Barcode||Your Loan Policy|